CMV
Clinical trials for CMV explained in plain language.
Never miss a new study
Get alerted when new CMV trials appear
Sign up with your email to follow new studies for CMV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung transplant patients battling dangerous virus
Disease control Recruiting nowThis study is testing whether adding a newer antiviral drug (letermovir) to the standard treatment helps clear a common and serious viral infection (CMV) faster in people who have received a lung transplant. The trial will involve 40 participants who have active CMV infection. Re…
Matched conditions: CMV
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New strategy aims to shield vulnerable transplant patients from dangerous virus
Prevention Recruiting nowThis study is testing if giving an antiviral drug called letermovir for a longer period (up to 24 weeks) can better prevent dangerous CMV infections in high-risk adults who have received a stem cell transplant from a donor. CMV is a common virus that can cause serious illness in …
Matched conditions: CMV
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC
-
New defense tested for transplant patients at risk of dangerous virus
Prevention Recruiting nowThis study is testing if a medication called CMVIG can prevent CMV infection in kidney transplant patients who are switching to a different anti-rejection drug called belatacept. Researchers will track how the body processes CMVIG and measure antibody levels over time in 30 adult…
Matched conditions: CMV
Phase: PHASE1, PHASE2 • Sponsor: University of Minnesota • Aim: Prevention
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt for hidden immune flaws behind severe virus cases
Knowledge-focused Recruiting nowThis study aims to understand why some otherwise healthy people get extremely sick from common viruses like herpes, flu, or chickenpox. Researchers will examine 600 participants who have had severe, long-lasting, or hard-to-treat viral infections, along with some of their family …
Matched conditions: CMV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC